New thyroid drug shows promise in phase 2 trial
Disease control
Completed
This study tested a new hormone replacement therapy called North Star against the standard drug levothyroxine for people with an underactive thyroid (hypothyroidism). 303 adults who were already stable on levothyroxine took part to see if North Star could control their thyroid ho…
Phase: PHASE2 • Sponsor: Neuvosyn Laboratories, LLC • Aim: Disease control
Last updated May 26, 2026 11:24 UTC